SRXH

SRx Health Solutions Inc. SRXH

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SRXH RDGT BOLT TNON TRIB CLRB SNSE AEON MRKR GELS
6M -45.10 % 222.22 % -9.33 % 19.49 % -68.86 % -67.71 % 22.19 % 49.95 % -12.07 % -46.88 %
YTD -85.22 % 112.20 % -53.95 % -49.79 % -81.38 % -71.03 % -9.13 % -97.18 % -59.91 % -64.29 %
1Y -85.22 % 112.20 % -47.86 % -43.77 % -77.03 % -60.43 % 8.84 % -97.61 % -65.82 % -68.75 %
3Y -85.22 % -95.67 % -79.96 % -99.27 % -96.86 % -92.59 % -69.21 % -99.83 % -56.03 % -71.09 %
5Y -85.22 % -98.61 % -99.18 % -99.94 % -99.17 % -99.65 % -97.52 % -99.83 % -91.88 % -71.09 %
10Y -85.22 % -99.22 % -99.18 % -99.94 % -99.70 % -99.99 % -97.52 % -99.83 % -98.26 % -71.09 %
From the beginning -85.22 % -98.79 % -99.18 % -99.94 % -99.78 % -100.00 % -97.52 % -99.83 % -100.00 % -71.09 %

Dividend

Bolt Biotherapeutics, Inc.

Trinity Biotech plc